Benefiting from the most efficient or adapted therapy to cure from disease and/or to be cured with the best quality of life during treatment


Providing innovative and non-invasive Blood-based In Vitro Diagnostic to predict patient response to a certain therapy


Making a diagnosis, treating, providing medical follow-up with the objective to personalize patient’s medical care in taking into account individual differences

GemciTest ®

The first diagnostic to predict the patient response in pancreatic cancer treatment


A rare and “silent” disease with no symptom early on, difficult to diagnose and cure.


A blood-based molecular test (RUO diagnostic) to predict patient’s therapeutic response


The less toxic and expensive chemotherapy in pancreatic cancer treatment


A combination of biomarkers to identify patients most likely to benefit from gemcitabine

To improve the patient’s quality of life during pancreatic cancer treatment

Our Expertises

Acobiom is an innovative biotechnology company specialized in the discovery of new biomarkers and in the development of innovative diagnostics.


Analyses of biological phenotypes; investigation of gene expression changes; Identification & validation of acid nucleic (DNA, RNA, miRNA, small RNA, coding & non coding RNA) biomarkers based on Sequencing/NGS & PCR technologies.


Treatments & analyses of sequencing/omics big data through a proprietary suite of Bioinformatic & Biostatistic tools; Development of a 21,000 Human RNA-Seq database, in-silico investigations through public & proprietary databases.


Biomarkers and diagnostics “to optimize a specific preventive, diagnostic or therapeutic intervention in a given subpopulation of patients, which would most likely to benefit from it”.


A unique scientific and technical expertise associated with 20-year experience in genomics & transcriptomics, in sequencing/NGS & PCR technologies, in performing RNA-Seq / ChIP-seq analyses, and PCR / qPCR / qRT-PCR experiences.

Latest News

World Pancreatic Cancer Day 2019 Banner

World Pancreatic Cancer Day 2019

On next November 21, 2019, the World Pancreatic Cancer Day 2019 will be organized. Key information about pancreatic cancer Pancreatic cancer is one of the world’s deadliest cancers. This cancer[…]

Read more
How Artificial Intelligence can help to the devlopment of diagnostics dedicated to Precision Medicine

How Artificial Intelligence can help to the development of diagnostics dedicated to Precision Medicine

Generating sequencing data from patient blood samples became easy to perform in clinical trials. But, analyzing the huge amount of genomic or transcriptomic data and extracting the key biomarkers associated[…]

Read more
The Cancer Center (CGFL) of Dijon evaluates the Acobiom’s GemciTest in clinics

The Cancer Center (CGFL) of Dijon evaluates the Acobiom’s GemciTest in clinics

The Cancer Center (CGFL) of Dijon (France) launches a clinical study in 2018 to evaluate the prognostic value of on the overall survival and response to major treatments in patients[…]

Read more

Since its foundation, Acobiom has always been at the forefront of Medical Innovation.

Acobiom was founded by Didier Ritter and Dr David Piquemal under the name « Skuldtech » to promote the gene expression profile (transcriptome) approach with the objective to discover RNA biomarkers, to develop diagnostics, and to improve the patient’s medical care.

Big Data - Acobiom

Contact us